Danilo Rocco
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Lung Cancer Research Studies
- COVID-19 and healthcare impacts
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 38
- Cancer Immunotherapy and Biomarkers 31
- Lung Cancer Research Studies 6
- Inflammatory Biomarkers in Disease Prognosis 2
- COVID-19 and healthcare impacts 2
-
- Lung Cancer Treatments and Mutations 39
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Umberto Malapelle (27 shared papers)Luigi Della Gravara (26 shared papers)Giancarlo Troncone (19 shared papers)Cesare Gridelli (19 shared papers)Claudio Bellevicine (13 shared papers)Pasquale Pisapia (10 shared papers)Andrea Bianco (6 shared papers)Fabio Perrotta (4 shared papers)
- Journals
- Journal of Clinical Pathology (5 papers)International Journal of Molecular Sciences (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)European Journal of Cancer (3 papers)Cancers (3 papers)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Danilo Rocco
70 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 71
- Oncology 776
- Pulmonary and Respiratory Medicine 644
- Cancer Research 260
- Molecular Biology 156
- Geriatrics and Gerontology 8
Countries citing papers authored by Danilo Rocco
This map shows the geographic impact of Danilo Rocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danilo Rocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danilo Rocco more than expected).
Fields of papers citing papers by Danilo Rocco
This network shows the impact of papers produced by Danilo Rocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danilo Rocco. The network helps show where Danilo Rocco may publish in the future.
Co-authors
The 25 scholars most cited alongside Danilo Rocco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 121 | |
| 2 | 2021 | 119 | |
| 3 | 2016 | 86 | |
| 4 | 2013 | 82 | |
| 5 | 2020 | 79 | |
| 6 | 2020 | 77 | |
| 7 | 2020 | 75 | |
| 8 | 2019 | 74 | |
| 9 | 2011 | 67 | |
| 10 | 2013 | 66 | |
| 11 | 2021 | 57 | |
| 12 | 2018 | 54 | |
| 13 | 2019 | 53 | |
| 14 | 2022 | 48 | |
| 15 | 2018 | 47 | |
| 16 | 2020 | 42 | |
| 17 | 2018 | 38 | |
| 18 | 2017 | 36 | |
| 19 | 2012 | 34 | |
| 20 | 2019 | 34 |
About Danilo Rocco
Danilo Rocco is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Dermatology, having authored 75 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (39 papers), Cancer Immunotherapy and Biomarkers (31 papers), Cancer Genomics and Diagnostics (6 papers), Lung Cancer Research Studies (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Extracellular vesicles in disease (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Oncology (776 citations), Pulmonary and Respiratory Medicine (644 citations), Cancer Research (260 citations), Molecular Biology (156 citations) and Geriatrics and Gerontology (8 citations). Danilo Rocco has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Umberto Malapelle, Luigi Della Gravara, Giancarlo Troncone, Cesare Gridelli, Claudio Bellevicine, Pasquale Pisapia, Andrea Bianco, Fabio Perrotta, Caterina De Luca and Francesco Pepe. Their work appears in journals such as Journal of Clinical Pathology, International Journal of Molecular Sciences, Journal for ImmunoTherapy of Cancer, European Journal of Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.